相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis
Liang Fang et al.
CANCER RESEARCH (2016)
Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer
Ji-Yeon Yang et al.
CLINICAL CANCER RESEARCH (2016)
FOXO factors and breast cancer: outfoxing endocrine resistance
M. Bullock
ENDOCRINE-RELATED CANCER (2016)
Activated Mutant p110α Causes Endometrial Carcinoma in the Setting of Biallelic Pten Deletion
Ayesha Joshi et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke
Masaru Ishida et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
Karine A. Cohen-Solal et al.
MOLECULAR CANCER (2015)
FOXO1 is Required for Binding of PR on IRF4, Novel Transcriptional Regulator of Endometrial Stromal Decidualization
Yasmin M. Vasquez et al.
MOLECULAR ENDOCRINOLOGY (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Affinity regression predicts the recognition code of nucleic acid-binding proteins
Raphael Pelossof et al.
NATURE BIOTECHNOLOGY (2015)
Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism
Zheng Hu et al.
NATURE GENETICS (2015)
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
David M. Hyman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Inference of transcriptional regulation in cancers
Peng Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Signaling pathways in HPV-associated cancers and therapeutic implications
Jiezhong Chen
REVIEWS IN MEDICAL VIROLOGY (2015)
The pioneer factor PBX1 is a novel driver of metastatic progression in ER'-positive breast cancer
Luca Magnani et al.
ONCOTARGET (2015)
Inferring regulatory element landscapes and transcription factor networks from cancer methylomes
Lijing Yao et al.
GENOME BIOLOGY (2015)
A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors
Philippe L. Bedard et al.
CLINICAL CANCER RESEARCH (2015)
Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks
James C. Chen et al.
CELL (2014)
Reverse-Phase Protein Array Profiling of Oropharyngeal Cancer and Significance of PIK3CA Mutations in HPV-Associated Head and Neck Cancer
Andrew Sewell et al.
CLINICAL CANCER RESEARCH (2014)
Linking signaling pathways to transcriptional programs in breast cancer
Hatice U. Osmanbeyoglu et al.
GENOME RESEARCH (2014)
Smad6 Suppresses the Growth and Self-Renewal of Hepatic Progenitor Cells
Ze-Yang Ding et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Use of Statins and the Risk of Death in Patients With Prostate Cancer
Oriana Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma
Yuexin Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
A community effort to assess and improve drug sensitivity prediction algorithms
James C. Costello et al.
NATURE BIOTECHNOLOGY (2014)
Activation of diverse signalling pathways by oncogenic PIK3CA mutations
Xinyan Wu et al.
NATURE COMMUNICATIONS (2014)
Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors
Filip Janku et al.
CELL REPORTS (2014)
Immunohistochemical study of pElk-1 expression in human breast cancer: Association with breast cancer biologic profile and clinicopathologic features
Aggelos Laliotis et al.
BREAST (2013)
PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System
Julia A. Beaver et al.
CLINICAL CANCER RESEARCH (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Network-based stratification of tumor mutations
Matan Hofree et al.
NATURE METHODS (2013)
Luminal breast cancer: from biology to treatment
Michail Ignatiadis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Development of PI3K inhibitors: lessons learned from early clinical trials
Jordi Rodon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer
Adrian Britschgi et al.
CANCER CELL (2012)
The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer
Julia A. Beaver et al.
FUTURE ONCOLOGY (2012)
Mutual exclusivity analysis identifies oncogenic network modules
Giovanni Ciriello et al.
GENOME RESEARCH (2012)
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer
Han Liang et al.
GENOME RESEARCH (2012)
Expression and Role of HMGA1 in Renal Cell Carcinoma
Natsuki Takaha et al.
JOURNAL OF UROLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes
T. Schepeler et al.
ONCOGENE (2012)
The ETS Transcription Factors ELK1 and GABPA Regulate Different Gene Networks to Control MCF10A Breast Epithelial Cell Migration
Zaneta Odrowaz et al.
PLOS ONE (2012)
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
Yasir H. Ibrahim et al.
CANCER DISCOVERY (2012)
ELK1 Uses Different DNA Binding Modes to Regulate Functionally Distinct Classes of Target Genes
Zaneta Odrowaz et al.
PLOS GENETICS (2012)
FoxO1 Mediates an Autofeedback Loop Regulating SIRT1 Expression
Shiqin Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Algorithms for Detecting Significantly Mutated Pathways in Cancer
Fabio Vandin et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer
E. P. Booy et al.
ONCOGENE (2011)
PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer
Luca Magnani et al.
PLOS GENETICS (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
Epidermal growth factor regulates PAI-1 expression via activation of the transcription factor Elk-1
Paulina Wyrzykowska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM
Charles J. Vaske et al.
BIOINFORMATICS (2010)
An Integrated Approach to Uncover Drivers of Cancer
Uri David Akavia et al.
CELL (2010)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
Automated Network Analysis Identifies Core Pathways in Glioblastoma
Ethan Cerami et al.
PLOS ONE (2010)
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2010)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery
Joanna Boros et al.
GENOME RESEARCH (2009)
Convergence of Integrins and EGF Receptor Signaling Via PI3K/Akt/FoxO Pathway in Early Gene Egr-1 Expression
Sara Cabodi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Evidence That Leptin Through STAT and CREB Signaling Enhances Cyclin D1 Expression and Promotes Human Endometrial Cancer Proliferation
Stefania Catalano et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Forkhead box O-class 1 and Forkhead box G1 as Prognostic Markers for Bladder Cancer
Tae-Hwan Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2009)
VHL Gene Mutations in Renal Cell Carcinoma: Role as a Biomarker of Disease Outcome and Drug Efficacy
C. Lance Cowey et al.
CURRENT ONCOLOGY REPORTS (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Identification of Pbx1, a Potential Oncogene, as a Notch3 Target Gene in Ovarian Cancer
Joon T. Park et al.
CANCER RESEARCH (2008)
Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck
William H. Westra et al.
CLINICAL CANCER RESEARCH (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Rev7/MAD2B links c-Jun N-terminal protein kinase pathway signaling to activation of the transcription factor Elk-1
Lin Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
PLZF regulates pbxl transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation
Tadahiko Kikugawa et al.
PROSTATE (2006)
Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?
JS Reis et al.
PATHOLOGY RESEARCH AND PRACTICE (2000)